Please enable JavaScript.
Coggle requires JavaScript to display documents.
Trichomoniasis (PATHOGENIC MICROBIOLOGY (Epidemiology (Malaysia…
Trichomoniasis
PATHOGENIC MICROBIOLOGY
Symptoms
For men
smeeling vaginal discharge-white,gray,yellow
genital redness,burning and itching
-
-
-
-
-
Epidemiology
In the United States, an estimated 3.7 million people have the infection. However, only about 30% develop any symptoms of trichomoniasis.
-
Older women are more likely than younger women to have been infected with trichomoniasis because of low immunity in an older women.
Malaysia Epidemiology
-
In Malaysia, there little cases or report has been made but is still possible for all three major ethnic groups
-
The overall prevalence rate of T. vaginalis infection in Iranian population was estimated to be minimally 0.4% and maximally 42%. The present review showed that T. vaginalis infection rate is relatively high among the Iranian population.
Treatment
Medication
-
-
Treated patient can be reinfected. To avoid getting reinfected, make sure that all your sex partners has undergone the treatment
-
-
Metronidazole - 2 g orally in a single dose (recommended)
Tinidazole - 2 g orally in a single dose (recommended)
Metronidazole - 500 mg orally twice a day for 7 days (alternative)
IMMUNOLOGY
How pathogen evades
Mucus is lowest in complement and during menses the blood plasma has the lowest levels of complement
Although cysteine proteases degrade the C3 portion of complement on the trichomonad surface the organism is protected against the lytic effects of complement.
Cysteine proteases also degrade IgG, IgM and IgA, which blunts the antibody response.
T. vaginalis secretes highly immunogenic soluble antigens and these may neutralize antibody or cytotoxic T cells.
T. vaginalis is able to become “invisible” to the immune system by coating its surface with host plasma proteins.
-
-
-
-
-
-